Pancreatic Insulinoma
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor (NCT02831179) | Vanderbilt-Ingram Cancer Center | 2017-12-01 |
| Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma (NCT01204476) | National Cancer Institute (NCI) | 2010-10-01 |
| Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer (NCT00454363) | National Cancer Institute (NCI) | 2007-03-01 |
Track Pancreatic Insulinoma automatically
Every clearance here is in the API, with alerts when new ones post.